Biovie Inc.
BIVINasdaqCIK 1580149HealthcareFiscal year ends Jun 30
Reports and events: 203 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-2817:13 ET | DEF 14A | Proxy statementPeriod 2026-09-28 | 0001520138-26-000395 |
| 2026-09-1418:16 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001520138-26-000391 |
| 2026-08-1417:23 ET | S-1/A | Registration statement, amended | 0001520138-26-000350 |
| 2026-08-1319:36 ET | 10-K | Annual reportPeriod 2026-06-30 | 0001520138-26-000332 |
| 2026-08-0607:41 ET | S-1/A | Registration statement, amended | 0001520138-26-000313 |
| 2026-08-0607:35 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001520138-26-000312 |
| 2026-07-3117:29 ET | S-1/A | Registration statement, amended | 0001520138-26-000299 |
| 2026-07-1717:21 ET | S-1 | Registration statement | 0001520138-26-000276 |
| 2026-05-1116:56 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001520138-26-000154 |
| 2026-03-2517:00 ET | SCHEDULE 13D | Ownership report, active investor | 0001520138-26-000086 |
| 2026-02-0617:01 ET | 10-Q | Quarterly reportPeriod 2025-12-31 | 0001520138-26-000052 |
| 2025-11-1317:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001520138-25-000352 |
| 2025-11-1217:06 ET | 8-K | 5.07 Shareholder vote results | 0001520138-25-000347 |
| 2025-11-1017:01 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001520138-25-000343 |
| 2025-09-2517:26 ET | DEF 14A | Proxy statementPeriod 2025-09-25 | 0001520138-25-000287 |
| 2025-08-1517:05 ET | 10-K | Annual reportPeriod 2025-06-30 | 0001520138-25-000268 |
| 2025-08-1116:25 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001520138-25-000249 |
| 2025-08-0408:52 ET | S-1/A | Registration statement, amended | 0001520138-25-000235 |
| 2025-07-2316:49 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001520138-25-000223 |
| 2025-07-2208:31 ET | S-1/A | Registration statement, amended | 0001520138-25-000216 |
| 2025-07-1117:19 ET | S-1/A | Registration statement, amended | 0001520138-25-000205 |
| 2025-07-0317:01 ET | S-1 | Registration statement | 0001520138-25-000198 |
| 2025-06-3020:35 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-064301 |
| 2025-06-2717:20 ET | 8-K | 3.03 Change to security holders’ rights | 0001520138-25-000190 |
| 2025-06-2417:20 ET | 8-K | 5.07 Shareholder vote results | 0001520138-25-000185 |
| 2025-06-0216:16 ET | DEF 14A | Proxy statementPeriod 2025-06-02 | 0001520138-25-000166 |
| 2025-05-1217:15 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001520138-25-000144 |
| 2025-03-2817:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001520138-25-000089 |
| 2025-02-1117:00 ET | 10-Q | Quarterly reportPeriod 2024-12-31 | 0001520138-25-000056 |
| 2024-11-2715:16 ET | S-1/A | Registration statement, amended | 0001520138-24-000434 |
| 2024-11-2117:29 ET | S-1 | Registration statement | 0001520138-24-000429 |
| 2024-11-1316:46 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001520138-24-000425 |
| 2024-11-0817:15 ET | 8-K | 5.07 Shareholder vote results | 0001520138-24-000410 |
| 2024-10-2916:15 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001520138-24-000404 |
| 2024-10-2906:00 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001520138-24-000400 |
| 2024-10-2416:15 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001520138-24-000387 |
| 2024-10-2409:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001520138-24-000379 |
| 2024-10-2216:01 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001520138-24-000376 |
| 2024-10-2208:48 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001520138-24-000372 |
| 2024-09-3017:08 ET | 10-K | Annual reportPeriod 2024-06-30 | 0001520138-24-000324 |
| 2024-09-2717:00 ET | DEF 14A | Proxy statementPeriod 2024-09-27 | 0001520138-24-000322 |
| 2024-09-2517:02 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001520138-24-000320 |
| 2024-09-2416:46 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001520138-24-000313 |
| 2024-09-2409:20 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001520138-24-000310 |
| 2024-08-2121:31 ET | 8-K | 8.01 Other events | 0001520138-24-000282 |
| 2024-08-0606:00 ET | 8-K/A | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001520138-24-000263 |
| 2024-08-0116:41 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001520138-24-000254 |
| 2024-07-3017:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001520138-24-000251 |
| 2024-06-2519:47 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-24-074862 |
| 2024-06-1717:05 ET | DEF 14A | Proxy statementPeriod 2024-06-17 | 0001520138-24-000228 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. Listed shows no prices and gives no investment advice.